High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019-Reference-Cited by-同舟云学术

High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019

Published:2020-03-01 Issue:3 Volume:7 Page:
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

Cao Wei¹,Liu Xiaosheng²,Bai Tao³,Fan Hongwei¹,Hong Ke³,Song Hui³,Han Yang¹,Lin Ling¹,Ruan Lianguo³,Li Taisheng¹

Affiliation:

1. Department of Infectious Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China

2. Tsinghua-Peking Center for Life Sciences, School of Medicine, Tsinghua University, Beijing, China

3. Department of Infectious Diseases, Jin Yin-tan Hospital, Wuhan, China

Abstract

Abstract The outbreak of coronavirus disease 2019 (COVID-19) has spread rapidly in China. Until now, no definite effective treatment has been identified. We reported on 3 patients with severe COVID-19 who received high-dose intravenous immunoglobulin (IVIg) with satisfactory recovery. Based on these observations, randomized studies of high-dose IVIg should be considered in deteriorating patients infected with COVID-19.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

Link

http://academic.oup.com/ofid/advance-article-pdf/doi/10.1093/ofid/ofaa102/32959155/ofaa102.pdf

Reference17 articles.

1. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China;Huang;Lancet,2020

2. A novel coronavirus from patients with pneumonia in China, 2019;Zhu;New Engl J Med,2020

3. CT imaging features of 2019 novel coronavirus (2019-nCoV);Chung;Radiology,2020

Cited by 317 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current development of severe acute respiratory syndrome coronavirus 2 neutralizing antibodies (Review);Molecular Medicine Reports;2024-06-26

2. The immune response of nano carbon-based photic-driving vaccines to severe acute respiratory syndrome coronavirus 2;Exploration of Immunology;2024-05-17

3. Integrated longitudinal multiomics study identifies immune programs associated with acute COVID-19 severity and mortality;Journal of Clinical Investigation;2024-05-01

4. Immunomodulatory Effect of COVID-19 on HLA-Antibody Profile in Renal Transplant Recipients;Journal of Clinical Medicine;2024-04-19

5. Monoclonal Antibodies and Hyperimmune Immunoglobulins in the Next Pandemic;Current Topics in Microbiology and Immunology;2024